SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:18901900.
  • 2
    Jacobs JP, Burke RP, Quintessenza JA, Mavroudis C. Congenital heart surgery nomenclature and database project: Ventricular septal defect. Ann Thorac Surg 2000;69:S25S35.
  • 3
    Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361368.
  • 4
    Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Catheter Cardiovasc Interv 2002;56:508315.
  • 5
    Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol 2006;47:319325.
  • 6
    Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006;68:620628.
  • 7
    Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects: Early and long-term results. J Am Coll Cardiol 2007;50:11891195.
  • 8
    Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg 2008;136:12231228.
  • 9
    Gatzoulis MA, Webb GD, Daubeneyet P. Diagnosis and Management of Adult Congenital Heart Disease, 2nd ed. Philadelphia: Elsevier; 2011. p 171.
  • 10
    Bass JL, Gruenstein D. Transcatheter closure of the perimembranous ventricular septal defect—Preclinical trial of a new Amplatzer device. Catheter Cardiovasc Interv 2012;79:11531160.
  • 11
    Velasco-Sanchez D, Tzikas A, Ibrahim R, Miró J. Transcatheter closure of perimembranous ventricular septal defects: Initial human experience with the Amplatzer® membranous VSD occluder 2. Catheter Cardiovasc Interv 2013;82:474–479.
  • 12
    Bass JL, Kalra GS, Arora R, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003;58:238245.
  • 13
    Zuo J, Xie J, Yi W, et al. Results of transcatheter closure of perimembranous ventricular septal defect. Am J Cardiol 2010;106:10341037.
  • 14
    Xunmin C, Shisen J, Jianbin G, Haidong W, Lijun W. Comparison of results and complications of surgical and Amplatzer device closure of perimembranous ventricular septal defects. Int J Cardiol 2007;120:2831.
  • 15
    Pedra CA, Pontes SC Jr, Pedra SR, et al. Percuta- neous closure of postoperative and past-traumatic ventricular septal defects. J Invasive Cardiol 2007;19:491495.
  • 16
    Zhou T, Shen XQ, Zhou SH, et al. Atrioventricular block: A serious complication in and after transcatheter closure of perimem- branous ventricular septal defects. Clin Cardiol 2008;31:368371.
  • 17
    Oses P, Hugues N, Dahdah N, et al. Treatment of isolated ventricular septal defects in children: Amplatzer versus surgical closure. Ann Thorac Surg 2010;90:15931598.
  • 18
    Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol 2005;96:52L58L.